NEOG

Healthcare

Neogen Corporation

Next Earnings: Q2 2026

Thursday, January 8, 2026

NEOG EPS History & Predictions

Actual

Consensus

Wall Street

$0.07consensus

Gemini 3 Pro

$0.05▼

GPT-5.2

$0.08▲

GPT-5.2

$0.06▼

Grok-4

$0.05▼

Claude-opus

$0.04▼

Q2 2026 Predictions

AI analyst forecasts for the upcoming earnings release. Click a model to see its reasoning.

Gemini 3 Pro

openrouter

EPS

$0.05

Revenue

$0.21B

Conf.

85%

Click for details →

GPT-5.2

openrouter

EPS

$0.08

Revenue

$0.22B

Conf.

44%

Click for details →

GPT-5.2

openrouter

EPS

$0.06

Revenue

$0.22B

Conf.

53%

Click for details →

Grok-4

openrouter

EPS

$0.05

Revenue

$0.21B

Conf.

75%

Click for details →

Claude-opus

openrouter

EPS

$0.04

Revenue

$0.21B

Conf.

72%

Click for details →

Predictions Comparison

AI model predictions compared to Wall Street consensus

Model	EPS Estimate	Revenue Estimate	vs Consensus	Confidence
Gemini 3 Proopenrouter	$0.05	$0.21B	-28.6%	85%
GPT-5.2openrouter	$0.08	$0.22B	+14.3%	44%
GPT-5.2openrouter	$0.06	$0.22B	-14.3%	53%
Grok-4openrouter	$0.05	$0.21B	-28.6%	75%
Claude-opusopenrouter	$0.04	$0.21B	-42.9%	72%
Wall Street Consensus	$0.07	$0.21B	—	—

Wall Street Consensus

Compare AI predictions against Wall Street analyst consensus

Consensus EPS

$-0.07

Last Reported EPS

$0.17

Last Surprise

329.73%

Report Date

10/9/2025

Quarterly Earnings Surprise Amount

Historical performance vs Wall Street consensus

Fiscal Quarter End	Date Reported	Earnings Per Share*	Consensus EPS* Forecast	% Surprise
Q1 2026	10/9/2025	0.17	—	329.73
Q4 2025	7/30/2025	-2.82	0.08	-3625.00
Q3 2025	4/9/2025	-0.05	0.13	-138.85
Q2 2025	1/15/2025	-2.10	0.09	-2433.33

* EPS values are adjusted for stock splits

Financial Statements

Historical data with AI projections for Q2 2026

All values in Millions (USD) unless otherwise noted

					AI Projections
Line Item	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Gemini 3 ProQ2 2026	GPT-5.2Q2 2026	GPT-5.2Q2 2026	Grok-4Q2 2026	Claude-opusQ2 2026
Revenue
Revenue	231.3	221.0	225.5	209.2	212.5+1.6%	218.0+4.2%	218.0+4.2%	212.0+1.3%	210.0+0.4%
Cost Of Revenue	141.5	134.0	156.1	137.2	136.0-0.9%	142.0+3.5%	140.6+2.5%	139.5+1.7%	137.0-0.2%
Cost & Gross Profit
Gross Profit	89.73	86.97	69.34	71.97	76.50+6.3%	76.00+5.6%	77.39+7.5%	72.50+0.7%	73.00+1.4%
Cost And Expenses	214.2	209.0	233.3	225.2	222.5-1.2%	225.3+0.1%	226.1+0.4%	224.7-0.2%	222.0-1.4%
Operating Expenses
Research And Development Expenses	5.11	4.47	6.31	5.13	5.20+1.5%	5.30+3.4%	5.20+1.5%	5.10-0.5%	5.00-2.4%
General And Administrative Expenses	0	0	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0	0	0
Selling General And Administrative Expenses	67.56	70.50	70.90	82.83	81.30-1.8%	78.00-5.8%	80.30-3.0%	80.60-2.7%	80.00-3.4%
Other Expenses	0	0	0	0	0	0	0	0	0
Operating Expenses	72.66	74.98	77.21	87.95	86.50-1.6%	83.30-5.3%	85.50-2.8%	85.70-2.6%	85.00-3.4%
Interest Expense	18.14	17.74	17.13	16.44	16.50+0.4%	15.20-7.6%	15.80-3.9%	16.40-0.3%	15.50-5.7%
Total Other Income Expenses Net	-493.6	-21.71	-623.3	59.79	-15.60-126.1%	28.80-51.8%	23.10-61.4%	-5.65-109.4%	9.30-84.4%
Income Tax Expense	-20.29	1.23	-19.01	7.47	-5.10-168.3%	4.10-45.1%	2.00-73.2%	-5.00-166.9%	6.00-19.7%
Other Income/Expense
Net Interest Income	-17.37	-17.04	-16.48	-15.52	-15.60-0.5%	-14.40+7.2%	-14.90+4.0%	-15.65-0.8%	-14.70+5.3%
Interest Income	0.774	0.699	0.644	0.918	0.900-2.0%	0.800-12.9%	0.900-2.0%	0.750-18.3%	0.800-12.9%
Non Operating Income Excluding Interest	475.5	3.98	606.2	-76.23	0+100.0%	42.90+156.3%	38.00+149.8%	10.00+113.1%	24.00+131.5%
Other Adjustments To Net Income	0	0	0	0	0	0	0	0	0
Net Income & EPS
Operating Income	17.07	11.99	-7.87	-15.98	-10.00+37.4%	-7.30+54.3%	-8.11+49.3%	-13.20+17.4%	-12.00+24.9%
Income Before Tax	-476.6	-9.73	-631.2	43.81	-25.60-158.4%	21.50-50.9%	15.00-65.8%	-30.00-168.5%	-2.70-106.2%
Net Income From Continuing Operations	-456.3	-10.96	-612.2	36.34	-20.50-156.4%	17.40-52.1%	13.00-64.2%	-25.00-168.8%	8.70-76.1%
Net Income From Discontinued Operations	0	0	0	0	0	0	0	0	0
Net Income	-456.3	-10.96	-612.2	36.34	-20.50-156.4%	17.40-52.1%	13.00-64.2%	-25.00-168.8%	8.70-76.1%
Net Income Deductions	0	0	0	0	0	0	0	0	0
Bottom Line Net Income	-456.3	-10.96	-612.2	36.34	-20.50-156.4%	17.40-52.1%	13.00-64.2%	-25.00-168.8%	8.70-76.1%
Eps	-$2.10	-$0.0505	-$2.82	$0.1700	-$0.0900-152.9%	$0.0800-52.9%	$0.0600-64.7%	$0.0500-70.6%	$0.0400-76.5%
Eps Diluted	-2.10	-0.05	-2.82	0.17	-0.09-152.9%	0.08-52.9%	0.06-64.7%	0.05-70.6%	0.04-76.5%
Other
Filing Date	0.002	0.002	0.002	0.002	—	—	—	—	—
Fiscal Year	0.002	0.002	0.002	0.002	—	—	—	—	—
Depreciation And Amortization	30.05	29.37	30.26	29.05	30.00+3.3%	29.50+1.5%	29.00-0.2%	29.10+0.2%	28.50-1.9%
Ebitda	-428.4	37.38	-583.8	89.31	20.90-76.6%	66.20-25.9%	58.90-34.0%	-13.00-114.6%	45.00-49.6%
Ebit	-458.4	8.01	-614.1	60.25	-9.10-115.1%	36.70-39.1%	29.90-50.4%	-42.10-169.9%	16.50-72.6%
Weighted Average Shs Out	216,813,788	217,031,907	217,040,499	217,040,499	217,200,000+0.1%	217,500,000+0.2%	217,200,000+0.1%	217,000,000-0.0%	217,500,000+0.2%
Weighted Average Shs Out Dil	216,813,788	217,031,907	217,040,499	217,040,499	217,200,000+0.1%	217,500,000+0.2%	217,200,000+0.1%	217,000,000-0.0%	217,500,000+0.2%